Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
Author(s) -
Sara Sadeghi,
Azadeh Goodarzi
Publication year - 2022
Publication title -
dermatology practical and conceptual
Language(s) - English
Resource type - Journals
ISSN - 2160-9381
DOI - 10.5826/dpc.1204a178
Subject(s) - tofacitinib , ruxolitinib , medicine , janus kinase , janus kinase inhibitor , vitiligo , psoriasis , rheumatoid arthritis , abatacept , alopecia areata , psoriatic arthritis , immunology , rheumatology , dermatology , rituximab , cytokine , bone marrow , lymphoma , myelofibrosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom